•   George Lundberg, MD

    Article from MDLinx curated by Editor in Chief George Lundberg, MD, who notes: 

    Very early detection of potentially lethal cancer remains an elusive goal. Blood tests that evaluate methylation of cell-free DNA may be one strategy for earlier detection of ovarian cancer and other types of cancer. High sensitivity and specificity are crucial.

    Go to full article published by MDLinx.

    If you’re wondering whether this story applies to your own cancer case or a loved one’s, we invite you to get support from Cancer Commons.

  •   George Lundberg, MD

    Article from EurekAlert curated by Editor in Chief George Lundberg, MD, who notes: 

    Researchers have shown that a combination therapy is effective against cancer cells in test-tube experiments and laboratory animals. It has not yet been tested in humans.

    Go to full article published by EurekAlert.

    If you’re wondering whether this story applies to your own cancer case or a loved one’s, we invite you to get support from Cancer Commons.

  •   George Lundberg, MD

    Article from Medical Xpress curated by Editor in Chief George Lundberg, MD, who notes: 

    Association is not causation. Yet, when the numbers are very high indeed, and the differences stark,  one had best take them seriously. People in the U.K. who drink coffee are half as likely to develop liver cancer, all known confounders considered.

    Go to full article published by Medical Xpress.

    If you’re wondering whether this story applies to your own cancer case or a loved one’s, we invite you to get support from Cancer Commons.

  •   George Lundberg, MD

    Research paper from the Journal of the Turkish-German Gynecological Association curated by Editor in Chief George Lundberg, MD, who notes: 

    Since many ovarian cancers arise in the adjacent fallopian tube, 20-40% of ovarian cancer can be prevented by prophylactic salpingectomy.

    Go to full paper published in the Journal of the Turkish-German Gynecological Association.

    If you’re wondering whether this story applies to your own cancer case or a loved one’s, we invite you to get support from Cancer Commons.

  •   George Lundberg, MD

    Article from Medscape curated by Editor in Chief George Lundberg, MD, who notes: 

    Always a profoundly difficult cancer to treat, liver cancer rates are greatly increasing, tripling in 20 years in the U.K. Prevention is an urgent need.

    Go to full article published by Medscape.

    If you’re wondering whether this story applies to your own cancer case or a loved one’s, we invite you to get support from Cancer Commons.

  •   George Lundberg, MD

    Research paper from Neuro-Oncology curated by Editor in Chief George Lundberg, MD, who notes: 

    Securing participation in clinical trials is a continuing and serious problem of clinical research for many cancers. This paper describes an effort to improve participation for brain cancer clinical trials.

    Go to full article published by Neuro-Oncology.

    If you’re wondering whether this story applies to your own cancer case or a loved one’s, we invite you to get support from Cancer Commons.

  •   George Lundberg, MD

    Article from MedPage Today curated by Editor in Chief George Lundberg, MD, who notes:

    Colorectal cancer (CRC) is one cancer is which screening and early diagnosis can make a real positive impact on survival. Thus, an increase in CRC in a younger age range should trigger more aggressive, earlier screening.

    Go to full article published by MedPage Today.

    If you’re wondering whether this story applies to your own cancer case or a loved one’s, we invite you to get support from Cancer Commons.

  •   George Lundberg, MD

    Research paper from the Journal of Molecular Diagnostics, selected by Editor in Chief George Lundberg, MD, who notes:

    Human papilloma virus (HPV) can cause cervical cancer. Tests for impending cervix cancer lack sensitivity and specificity. This new test promises to improve both.

    Go to full paper published in the Journal of Molecular Diagnostics.

    If you’re wondering whether this story applies to your own cancer case or a loved one’s, we invite you to get support from Cancer Commons.

  •   George Lundberg, MD

    Excerpt from Cancer Network:

    “A deep learning approach to assessing cancer outcomes appears feasible, according to results of a study in patients with lung cancer. Machine curation yielded similarly accurate assessments of progression and times to improvement and response compared with human counterparts. This development could speed up oncology care processes.

    ” ‘Important clinical end points, such as response to therapy and disease progression, are often recorded in the EHR [electronic health record] only as unstructured text,’ wrote authors led by Kenneth L. Kehl, MD, MPH, of the Dana-Farber Cancer Institute in Boston. Standards such as RECIST are not routinely applied outside of clinical trials.”

    Go to full article published by Cancer Network.

    If you’re wondering whether this story applies to your own cancer case or a loved one’s, we invite you to get support from Cancer Commons.

  •  

    Can Preclinical Data Guide Clinical Cancer Therapy?

    With: Keith Flaherty, MD

    A Q&A with Keith Flaherty, MD, Associate Professor of Medicine, Harvard Medical School; Director of Developmental Therapeutics, Cancer Center, Massachusetts General Hospital; kflaherty@mgh.harvard.edu Originally published Aug 31, 2016 Q: Under what circumstances and to what extent are you willing to take clinical actions on a cancer patient based primarily on preclinical data? A: There are two scenarios that come to mind when thinking about… Read more »